Legal status in Switzerland

Per-substance legal status for Switzerland, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

87 confirmed substances1 not individually verifiedLast updated September 20, 2026

Confirmed legal status

1P-LSD

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 1P-LSD in list e, where the entry reads „1P-LSD“. The prodrug is named in its own right in the broader list rather than being left to the LSD entry. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „1P-LSD“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The prodrug is named in its own right in the broader list rather than being left to the LSD entry. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 1P-LSD sits in list e of BetmVV-EDI, entered as „1P-LSD“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as 1P-LSD, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 1P-LSD was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 1P-LSD into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „1P-LSD“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 1P-LSD: BetmVV-EDI Annex · list e · art. 1(2), entry „1P-LSD“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

1P-LSD in Switzerland, full detail →

2-FDCK

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 2-FDCK in list d, where the entry reads „2-Fluordeschlorketamin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „2-Fluordeschlorketamin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 2-FDCK sits in list d of BetmVV-EDI, entered as „2-Fluordeschlorketamin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 2-FDCK, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 2-FDCK was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 2-FDCK into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „2-Fluordeschlorketamin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 2-FDCK: BetmVV-EDI Annex · list d · art. 1(2), entry „2-Fluordeschlorketamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

2-FDCK in Switzerland, full detail →

25I-NBOMe

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 25I-NBOMe in list d, where the entry reads „25I-NBOMe“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „25I-NBOMe“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 25I-NBOMe sits in list d of BetmVV-EDI, entered as „25I-NBOMe“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 25I-NBOMe, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 25I-NBOMe was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 25I-NBOMe into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „25I-NBOMe“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 25I-NBOMe: BetmVV-EDI Annex · list d · art. 1(2), entry „25I-NBOMe“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

25I-NBOMe in Switzerland, full detail →

2C-B

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 2C-B in list d, where the entry reads „2C-B“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „2C-B“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 2C-B sits in list d of BetmVV-EDI, entered as „2C-B“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 2C-B, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 2C-B was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 2C-B into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „2C-B“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 2C-B: BetmVV-EDI Annex · list d · art. 1(2), entry „2C-B“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

2C-B in Switzerland, full detail →

2C-E

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 2C-E in list e, where the entry reads „2C-E“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „2C-E“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 2C-E sits in list e of BetmVV-EDI, entered as „2C-E“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as 2C-E, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 2C-E was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 2C-E into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „2C-E“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 2C-E: BetmVV-EDI Annex · list e · art. 1(2), entry „2C-E“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

2C-E in Switzerland, full detail →

2C-I

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 2C-I in list d, where the entry reads „2C-I“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „2C-I“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 2C-I sits in list d of BetmVV-EDI, entered as „2C-I“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 2C-I, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 2C-I was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 2C-I into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „2C-I“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 2C-I: BetmVV-EDI Annex · list d · art. 1(2), entry „2C-I“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

2C-I in Switzerland, full detail →

2C-T-7

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 2C-T-7 in list d, where the entry reads „2C-T-7“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „2C-T-7“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 2C-T-7 sits in list d of BetmVV-EDI, entered as „2C-T-7“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 2C-T-7, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 2C-T-7 was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 2C-T-7 into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „2C-T-7“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 2C-T-7: BetmVV-EDI Annex · list d · art. 1(2), entry „2C-T-7“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

2C-T-7 in Switzerland, full detail →

3-MMC

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 3-MMC in list d, where the entry reads „3-Methylmethcathinon“. The ring substituted cathinone is named individually rather than being left to a family description. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „3-Methylmethcathinon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The ring substituted cathinone is named individually rather than being left to a family description. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 3-MMC sits in list d of BetmVV-EDI, entered as „3-Methylmethcathinon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 3-MMC, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 3-MMC was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 3-MMC into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „3-Methylmethcathinon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 3-MMC: BetmVV-EDI Annex · list d · art. 1(2), entry „3-Methylmethcathinon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

3-MMC in Switzerland, full detail →

4-AcO-DMT

Legal status: Controlled as an ester of a listed substance. 4-AcO-DMT is not separately named, and it is reached instead by the express ester extension in BetmVV-EDI article 1(2)(b) applied to the list d entry for psilocin, the ordinance covering „Ester... der kontrollierten Substanzen“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Psilocin“; „Ester... der kontrollierten Substanzen“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. 4-AcO-DMT is not separately named and is reached by the express ester extension in BetmVV-EDI article 1(2)(b) applied to the list d entry for psilocin. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 4-AcO-DMT sits in list d of BetmVV-EDI, entered as „Psilocin“; „Ester... der kontrollierten Substanzen“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as 4-AcO-DMT, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 4-AcO-DMT was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 4-AcO-DMT into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Psilocin“; „Ester... der kontrollierten Substanzen“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 4-AcO-DMT: BetmVV-EDI art. 1(2)(b) · Annex 5, list d, entry „Psilocin“ · „Ester... der kontrollierten Substanzen“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

4-AcO-DMT in Switzerland, full detail →

4-HO-MET

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 4-HO-MET in list e, where the entry reads „4-HO-MET“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „4-HO-MET“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 4-HO-MET sits in list e of BetmVV-EDI, entered as „4-HO-MET“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as 4-HO-MET, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 4-HO-MET was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 4-HO-MET into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „4-HO-MET“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 4-HO-MET: BetmVV-EDI Annex · list e · art. 1(2), entry „4-HO-MET“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

4-HO-MET in Switzerland, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 5-MeO-DMT in list e, where the entry reads „5-MeO-DMT“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „5-MeO-DMT“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 5-MeO-DMT sits in list e of BetmVV-EDI, entered as „5-MeO-DMT“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as 5-MeO-DMT, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 5-MeO-DMT was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 5-MeO-DMT into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „5-MeO-DMT“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 5-MeO-DMT: BetmVV-EDI Annex · list e · art. 1(2), entry „5-MeO-DMT“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

5-MeO-DMT (Bufo / Toad) in Switzerland, full detail →

6-APB

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 6-APB in list e, where the entry reads „6-APB“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „6-APB“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 6-APB sits in list e of BetmVV-EDI, entered as „6-APB“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as 6-APB, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 6-APB was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 6-APB into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „6-APB“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 6-APB: BetmVV-EDI Annex · list e · art. 1(2), entry „6-APB“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

6-APB in Switzerland, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries 7-hydroxymitragynine in list a, where the entry reads „7-Hydroxymitragynin“. The metabolite is listed in its own right as well as being one of the two alkaloids that answer the kratom row. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „7-Hydroxymitragynin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The metabolite is listed in its own right as well as being one of the two alkaloids that answer the kratom row. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: 7-hydroxymitragynine sits in list a of BetmVV-EDI, entered as „7-Hydroxymitragynin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as 7-hydroxymitragynine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to 7-hydroxymitragynine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no 7-hydroxymitragynine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „7-Hydroxymitragynin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, 7-hydroxymitragynine: BetmVV-EDI Annex · list a · art. 1(2), entry „7-Hydroxymitragynin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

7-Hydroxymitragynine (7-OH) in Switzerland, full detail →

Adderall

Legal status: Controlled through its constituent. Adderall is a brand and formulation label rather than an entry in the Swiss ordinance, and the amphetamine it contains is what the schedule reaches: BetmVV-EDI carries amphetamine in list a, entered as „Amphetamin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Amphetamin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Adderall is a brand and formulation label rather than an entry in the ordinance, and it is the amphetamine it contains that the schedule reaches. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Adderall sits in list a of BetmVV-EDI, entered as „Amphetamin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as Adderall, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to Adderall was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no Adderall into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Amphetamin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Adderall: BetmVV-EDI Annex · list a · art. 1(2), entry „Amphetamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Adderall in Switzerland, full detail →

Alcohol

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for alcohol. The German search term checked was „Alkohol / Ethanol“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry alcohol, and separate product, medicines, food, tobacco or poisons law may still apply. Ethanol is governed by alcohol, food and road traffic law in Switzerland, none of which this row reaches.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for alcohol under the search term „Alkohol / Ethanol“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. Ethanol is governed by alcohol, food and road traffic law in Switzerland, none of which this row reaches.
If prescribed / medical: Alcohol is not carried in lists a to e of BetmVV-EDI, the search under „Alkohol / Ethanol“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as alcohol. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry alcohol only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Alkohol / Ethanol“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Alcohol: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Alkohol / Ethanol“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Alcohol in Switzerland, full detail →

Amphetamine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries amphetamine in list a, where the entry reads „Amphetamin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Amphetamin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Amphetamine sits in list a of BetmVV-EDI, entered as „Amphetamin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as amphetamine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to amphetamine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no amphetamine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Amphetamin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Amphetamine: BetmVV-EDI Annex · list a · art. 1(2), entry „Amphetamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Amphetamine in Switzerland, full detail →

Amyl Nitrite

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for amyl nitrite. The German search term checked was „Amylnitrit“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry amyl nitrite, and separate product, medicines, food, tobacco or poisons law may still apply. The result is proved for this nitrite alone and does not carry across to the other alkyl nitrites sold under the same use name.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for amyl nitrite under the search term „Amylnitrit“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. The result is proved for this nitrite alone and does not carry across to the other alkyl nitrites sold under the same use name.
If prescribed / medical: Amyl nitrite is not carried in lists a to e of BetmVV-EDI, the search under „Amylnitrit“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as amyl nitrite. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry amyl nitrite only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Amylnitrit“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Amyl nitrite: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Amylnitrit“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Amyl Nitrite in Switzerland, full detail →

Ayahuasca

Legal status: Controlled through its actual DMT content. The vernacular name of the brew is not a schedule entry, and BetmVV-EDI carries the tryptamine in list d, entered as „Dimethyltryptamin (DMT)“, so a liquid is assessed by what it contains. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Dimethyltryptamin (DMT)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The vernacular name of the brew is not a schedule entry, so a liquid is assessed by the tryptamine it contains rather than by what it is called. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Ayahuasca sits in list d of BetmVV-EDI, entered as „Dimethyltryptamin (DMT)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as ayahuasca, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to ayahuasca was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no ayahuasca into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Dimethyltryptamin (DMT)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Ayahuasca: BetmVV-EDI Annex · list d · art. 1(2), entry „Dimethyltryptamin (DMT)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Ayahuasca in Switzerland, full detail →

Barbiturates

Legal status: Controlled in Switzerland member by member rather than as a class, and this is a finding rather than a deferral because the country's own schedule names the members. The member by member check was run against the SWITZERLAND SCHEDULE and not merely against the substances this table happens to carry, and it returned named members: the BetmVV-EDI lists a to e classify barbiturates member by member and the class row names „Barbital; Secobarbital“, that is barbital and secobarbital. That distinction decides the cell. No barbiturate has a row of its own among the 88 substances in this table, but a schedule that names individuals is not silent merely because the table is, and the absence of a row here is a fact about this table rather than about Switzerland. So the specific barbiturate must be identified before any answer is given, and that is the finding: the schedule placement, and therefore the penalty, differs between the named members, so naming the product is the whole of the question.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term, so where a named barbiturate is involved the ceiling is 20 years, with BetmG article 19(2) defining the aggravated forms and StGB article 40 supplying the maximum. The penalty follows the identified member rather than the word barbiturates: the entries recorded against this row are „Barbital; Secobarbital“, a preparation containing one of them engages article 19 through that constituent, and a compound appearing in no list engages it not at all. This build did not record which list letter carries those two entries, and this table carries no barbiturate member row of its own, so no band is stated for the label here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: A barbiturate is answered by its member, and the member's list placement is what any personal use rule attaches to. The country level rule this dossier establishes is BetmG article 19a for unauthorised consumption and article 19b for a negligible quantity prepared for one's own use, with article 19b(2) fixing that quantity at 10 g of cannabis and at no other substance, so neither barbital nor secobarbital is given a stated margin. No prescription or traveller route specific to the barbiturate class was established in this dossier, and a prescribed barbiturate medicine has to be justified by whatever authorisation its own named entry requires.
Documentation: Carry a prescribed barbiturate in its original dispensing packaging with the prescription naming the active ingredient, because the identity of the member is what the Swiss schedules turn on and the words on the box are what identify it. The provenance is BetmVV-EDI in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, which records „Barbital; Secobarbital“ as individually named entries; the source dossier classified this row as not applicable, and that treatment is corrected here because the ordinance plainly names members of the class.

Switzerland, Barbiturates: BetmVV-EDI named member entries „Barbital · Secobarbital“ with the article 1(2) extensions, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · class resolved member by member instead of being left as not applicable, and the list letter for those two entries is not recorded by the source. · Updated September 20, 2026

Barbiturates in Switzerland, full detail →

Benzodiazepines

Legal status: Controlled by member, and in this table every member resolves to list b. The ordinance carries no class heading for benzodiazepines; it names compounds, and the source row records „Alprazolam; Clonazepam; Diazepam; Lorazepam“. Six members are answered individually elsewhere in this same table and all six sit in list b of BetmVV-EDI: alprazolam, clonazepam, diazepam, etizolam, lorazepam and nimetazepam. The class label covers the 1,4 and 1,5 benzodiazepine sedatives and hypnotics together with the thienodiazepine etizolam, which the ordinance names in its own right. A designer benzodiazepine that is not separately named is controlled only where one of the defined families in list e reaches it or an article 1(2) extension does, because resemblance to a named benzodiazepine is not itself a schedule rule.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the drug act authorises no life term, so a list b benzodiazepine carries the same 20 year ceiling as the rest of the schedule, set by BetmG article 19(2) for the aggravated forms and by StGB article 40 for the maximum itself. The list b placement is what decides the band, and the six members this table settles, alprazolam, clonazepam, diazepam, etizolam, lorazepam and nimetazepam, all sit there. An unnamed designer compound engages article 19 only where a defined family in list e or an article 1(2) extension catches it, so the member has to be identified before any figure is quoted. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Every benzodiazepine answered in this table sits in list b, so list b is the placement to attach to the country level rule. That rule is the personal use regime: BetmG article 19a keeps unauthorised consumption punishable, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes the negligible quantity at 10 g of cannabis and at nothing else, so no stated margin exists for alprazolam, clonazepam, diazepam, etizolam, lorazepam or nimetazepam. No traveller certificate route for a prescribed list b medicine was established in this dossier.
Documentation: Carry a prescribed benzodiazepine in its original dispensing packaging with the prescription naming the compound, since Swiss control is by named member and the box is what shows whether the medicine is one of the list b entries. The provenance is BetmVV-EDI list b in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, cross read against the individual rows for alprazolam, clonazepam, diazepam, etizolam, lorazepam and nimetazepam in this same table; the source dossier marked the class not applicable, and that treatment is corrected here.

Switzerland, Benzodiazepines: BetmVV-EDI list b entries for alprazolam, clonazepam, diazepam, etizolam, lorazepam and nimetazepam, with the article 1(2) extensions, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · resolved member by member from the verified rows of the same table instead of being left as not applicable. · Updated September 20, 2026

Benzodiazepines in Switzerland, full detail →

Buprenorphine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries buprenorphine in list a, where the entry reads „Buprenorphin“. The entry stands whether the product is a treatment formulation or not. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Buprenorphin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Buprenorphine sits in list a of BetmVV-EDI, entered as „Buprenorphin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as buprenorphine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to buprenorphine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no buprenorphine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Buprenorphin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Buprenorphine: BetmVV-EDI Annex · list a · art. 1(2), entry „Buprenorphin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Buprenorphine in Switzerland, full detail →

Caffeine

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for caffeine. The German search term checked was „Coffein / Koffein“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry caffeine, and separate product, medicines, food, tobacco or poisons law may still apply. Food law governs caffeinated products, and this row settles only the drug schedules.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for caffeine under the search term „Coffein / Koffein“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. Food law governs caffeinated products, and this row settles only the drug schedules.
If prescribed / medical: Caffeine is not carried in lists a to e of BetmVV-EDI, the search under „Coffein / Koffein“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as caffeine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry caffeine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Coffein / Koffein“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Caffeine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Coffein / Koffein“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Caffeine in Switzerland, full detail →

Cannabinol

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for cannabinol. The German search term checked was „Cannabinol“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry cannabinol, and separate product, medicines, food, tobacco or poisons law may still apply. The oxidation product of THC is not the THC isomer entry, and this row proves only the absence of an entry under its own name.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for cannabinol under the search term „Cannabinol“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. The oxidation product of THC is not the THC isomer entry, and this row proves only the absence of an entry under its own name.
If prescribed / medical: Cannabinol is not carried in lists a to e of BetmVV-EDI, the search under „Cannabinol“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as cannabinol. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry cannabinol only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Cannabinol“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Cannabinol: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Cannabinol“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Cannabinol in Switzerland, full detail →

Cannabis / THC

Legal status: Controlled, and split by purpose. BetmVV-EDI carries medical cannabis in list a, while cannabis and cannabis products for non medical purposes sit in list d, the entry reading „Cannabis; Cannabisprodukte... zu nicht-medizinischen Zwecken“. Article 1(2) extends that entry to preparations, so a product is classified by what it contains and what it is for rather than by its trade name. The one federal quantity figure in the whole Swiss regime attaches here: BetmG article 19b(2) fixes 10 g of cannabis as a negligible quantity, and the Federal Supreme Court held in 6B_1273/2016 that sole possession of up to 10 g for one's own consumption is a nonpunishable preparatory act. BGE 149 IV 307, judgment 6B_911/2021 of 19 June 2023, held that such cannabis cannot be confiscated where no offence exists. Consumption itself remains punishable under article 19a.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the schedule placement: BetmVV-EDI carries medical cannabis in list a, while cannabis for non medical purposes sits in list d at the entry „Cannabis; Cannabisprodukte... zu nicht-medizinischen Zwecken“. Below the trafficking articles the position is unusually precise for Switzerland: article 19b(2) makes 10 g a negligible quantity as a matter of federal law rather than cantonal tolerance, sole possession of that amount for own use is nonpunishable on the authority of 6B_1273/2016, and BGE 149 IV 307 bars confiscation where no offence exists. Cantonal police and prosecutors administer the rule and enforcement practice has historically differed between them, but a canton cannot replace the federal figure. Actual consumption stays punishable under BetmG article 19a and, for an adult in the statutory conditions, may be dealt with by the CHF 100 fixed fine. This is one of the reasons Switzerland fits none of the three threshold models cleanly: a statutory figure for one substance sits alongside court set thresholds for the aggravated serious case.
If prescribed / medical: Cannabis is the single substance for which the Swiss personal use rule states a figure, and that figure is the country level rule this dossier establishes. BetmG article 19b(2) fixes 10 g as the negligible quantity, article 19b makes preparation of that quantity for one's own consumption nonpunishable along with qualifying free sharing for simultaneous joint consumption, and article 19a leaves consumption itself punishable, with a CHF 100 fixed fine available against an adult. Because the medical product sits in list a and the non medical product in list d, the purpose of the article decides which side of the ordinance it falls on. No traveller certificate route for bringing prescribed cannabis into Switzerland was established in this dossier, so the 10 g rule must not be read as an import allowance.
Documentation: Carry no more than the federal negligible quantity of 10 g if you carry cannabis at all, keep it to your own consumption, and carry a prescribed cannabis medicine in its original dispensing packaging with the prescription, because the list a medical entry and the list d non medical entry are separated by purpose and the packaging is what shows which one applies. The provenance is BetmVV-EDI lists a and d in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, together with BetmG articles 19, 19a and 19b, Federal Supreme Court judgment 6B_1273/2016 and BGE 149 IV 307, judgment 6B_911/2021 of 19 June 2023.

Switzerland, Cannabis: BetmVV-EDI list a for medical cannabis and list d for cannabis and cannabis products for non medical purposes, article 1(2), at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · Federal Supreme Court 6B_1273/2016 at https://www.bger.ch/ext/eurospider/live/de/php/aza/http/index.php?highlight_docid=aza%3A%2F%2F06-09-2017-6B_1273-2016 · BGE 149 IV 307 at https://relevancy.bger.ch/cgi-bin/JumpCGI?id=BGE-149-IV-307 · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Cannabis / THC in Switzerland, full detail →

Cathinone

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries cathinone in list d, where the entry reads „Cathinon“. The parent ketone is listed separately from the khat plant material and from the substituted cathinones. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Cathinon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Cathinone sits in list d of BetmVV-EDI, entered as „Cathinon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as cathinone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to cathinone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no cathinone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Cathinon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Cathinone: BetmVV-EDI Annex · list d · art. 1(2), entry „Cathinon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Cathinone in Switzerland, full detail →

CBD

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for CBD. The German search term checked was „Cannabidiol (CBD)“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry CBD, and separate product, medicines, food, tobacco or poisons law may still apply. A cannabidiol product can still be caught through its residual THC content, which is a different entry and a different question from this one.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for CBD under the search term „Cannabidiol (CBD)“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. A cannabidiol product can still be caught through its residual THC content, which is a different entry and a different question from this one.
If prescribed / medical: CBD is not carried in lists a to e of BetmVV-EDI, the search under „Cannabidiol (CBD)“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as CBD. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry CBD only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Cannabidiol (CBD)“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, CBD: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Cannabidiol (CBD)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

CBD in Switzerland, full detail →

Clonazepam

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries clonazepam in list b, where the entry reads „Clonazepam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Clonazepam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Clonazepam sits in list b of BetmVV-EDI, entered as „Clonazepam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as clonazepam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to clonazepam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no clonazepam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Clonazepam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Clonazepam: BetmVV-EDI Annex · list b · art. 1(2), entry „Clonazepam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Clonazepam in Switzerland, full detail →

Cocaine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries cocaine in list a, where the entry reads „Cocain“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Cocain“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Cocaine sits in list a of BetmVV-EDI, entered as „Cocain“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as cocaine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to cocaine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no cocaine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Cocain“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Cocaine: BetmVV-EDI Annex · list a · art. 1(2), entry „Cocain“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Cocaine in Switzerland, full detail →

Codeine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries codeine in list a, where the entry reads „Codein“. The methylmorphine is listed in its own right, separately from morphine. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Codein“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Codeine sits in list a of BetmVV-EDI, entered as „Codein“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as codeine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to codeine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no codeine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Codein“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Codeine: BetmVV-EDI Annex · list a · art. 1(2), entry „Codein“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Codeine in Switzerland, full detail →

Crack Cocaine

Legal status: Controlled as a form of cocaine. Crack is a preparation of cocaine rather than a separate entry, and BetmVV-EDI carries cocaine in list a, entered as „Cocain“, with the preparation limb of article 1(2) reaching the smokeable form. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Cocain“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Crack is a preparation of cocaine rather than a separate entry, and the preparation limb of article 1(2) is what reaches the smokeable form. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Crack cocaine sits in list a of BetmVV-EDI, entered as „Cocain“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as crack cocaine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to crack cocaine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no crack cocaine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Cocain“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Crack cocaine: BetmVV-EDI Annex · list a · art. 1(2), entry „Cocain“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Crack Cocaine in Switzerland, full detail →

Delta-8-THC

Legal status: Controlled as a THC isomer. BetmVV-EDI does not name Delta 8 THC on its own; it carries a single list d entry reading „Tetrahydrocannabinol (THC), alle Isomere und deren stereochemische Varianten ausser (-)-trans-Δ9-THC“, which reaches every THC isomer and stereochemical variant except the one dealt with through the cannabis entries. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Tetrahydrocannabinol (THC), alle Isomere und deren stereochemische Varianten ausser (-)-trans-Δ9-THC“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Delta-8-THC is not named on its own, and that single entry reaches every THC isomer and stereochemical variant except the one dealt with through the cannabis entries. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Delta 8 THC sits in list d of BetmVV-EDI, entered as „Tetrahydrocannabinol (THC), alle Isomere und deren stereochemische Varianten ausser (-)-trans-Δ9-THC“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as Delta 8 THC, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to Delta 8 THC was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no Delta 8 THC into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Tetrahydrocannabinol (THC), alle Isomere und deren stereochemische Varianten ausser (-)-trans-Δ9-THC“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Delta 8 THC: BetmVV-EDI Annex · list d · art. 1(2), entry „Tetrahydrocannabinol (THC), alle Isomere und deren stereochemische Varianten ausser (-)-trans-Δ9-THC“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Delta-8-THC in Switzerland, full detail →

Diazepam

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries diazepam in list b, where the entry reads „Diazepam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Diazepam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Diazepam sits in list b of BetmVV-EDI, entered as „Diazepam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as diazepam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to diazepam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no diazepam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Diazepam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Diazepam: BetmVV-EDI Annex · list b · art. 1(2), entry „Diazepam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Diazepam in Switzerland, full detail →

DMT

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries DMT in list d, where the entry reads „Dimethyltryptamin (DMT)“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Dimethyltryptamin (DMT)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: DMT sits in list d of BetmVV-EDI, entered as „Dimethyltryptamin (DMT)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as DMT, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to DMT was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no DMT into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Dimethyltryptamin (DMT)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, DMT: BetmVV-EDI Annex · list d · art. 1(2), entry „Dimethyltryptamin (DMT)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

DMT in Switzerland, full detail →

DOM

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries DOM in list d, where the entry reads „DOM“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „DOM“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: DOM sits in list d of BetmVV-EDI, entered as „DOM“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as DOM, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to DOM was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no DOM into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „DOM“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, DOM: BetmVV-EDI Annex · list d · art. 1(2), entry „DOM“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

DOM in Switzerland, full detail →

DXM

Legal status: Not controlled, and by an express exclusion rather than by silence. Annex 2, list a of BetmVV-EDI states „Dextromethorphan untersteht nicht der Kontrolle.“, that dextromethorphan is not subject to control. That is a stronger result than a failed search: the ordinance has considered the substance and put it outside the controlled set, so the article 1(2) extensions for salts, esters, ethers, carbamates, stereoisomers and preparations have nothing to attach to. Medicines law still governs how a dextromethorphan preparation is sold and supplied.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and no BetmG article 19 ceiling attaches to dextromethorphan either, because the ordinance expressly excludes it: Annex 2, list a of BetmVV-EDI states „Dextromethorphan untersteht nicht der Kontrolle.“, and the drug act's offence articles operate only on controlled substances. Neither the aggravated forms in article 19(2) nor the 20 year maximum in StGB article 40 is engaged by the substance itself, and the article 1(2) extensions have nothing to attach to. What remains is ordinary medicines and product law, together with the general criminal law where separate conduct such as driving under the influence is in issue.
If prescribed / medical: Dextromethorphan sits outside lists a to e by an express exclusion, so there is no controlled substance authorisation to carry for it. The country level rule this dossier establishes is the personal use regime of BetmG articles 19a and 19b, whose only stated quantity is the 10 g of cannabis fixed by article 19b(2), and none of it reaches an expressly excluded substance. Whether a particular cough preparation is prescription only or sold over the counter is a medicines law question that this dossier did not settle.
Documentation: Carry a dextromethorphan preparation in its original packaging with the pharmacy labelling, since the exclusion is written against the substance and the packaging is what identifies the product. The provenance is the express exclusion at Annex 2, list a of BetmVV-EDI in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, where the text reads „Dextromethorphan untersteht nicht der Kontrolle.“ and no other list carries the substance.

Switzerland, DXM: BetmVV-EDI Annex 2, list a, express exclusion „Dextromethorphan untersteht nicht der Kontrolle.“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

DXM in Switzerland, full detail →

Ephedrine

Legal status: Controlled as a precursor rather than as a drug. Ephedrine is handled in list f, the precursor list at Annex 7 of BetmVV-EDI, where the entry covers „Ephedrinhaltige Präparate“, preparations containing ephedrine, with stated exemptions for low dose preparations at 15 mg per dosage unit or 10 mg per millilitre. It is not in lists a to e, so the drug schedules are not what govern it. The ordinance keeps the precursor list f and the auxiliary chemical list g distinct from the drug lists, and the obligations attaching to a precursor are licensing, record keeping and control of trade rather than the offence structure of article 19.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and this row assigns no BetmG article 19 drug ceiling either, because ephedrine's placement is list f, the precursor list at Annex 7 of BetmVV-EDI, where the entry covers „Ephedrinhaltige Präparate“ with stated exemptions at 15 mg per dosage unit or 10 mg per millilitre. It is not in lists a to e, so the aggravated forms in article 19(2) and the 20 year maximum that StGB article 40 supplies for drug offences are not engaged by holding a list f preparation as such. What attaches instead is licensing, record keeping and control of trade. Diversion of a precursor towards illicit manufacture is a different matter, reached by the precursor regime and by participation in whatever drug offence the manufacture itself constitutes.
If prescribed / medical: Ephedrine sits in list f rather than in lists a to e, and the low dose exemptions at 15 mg per dosage unit or 10 mg per millilitre mean that many finished medicines fall outside the controlled preparation entry altogether. The country level rule this dossier establishes is the personal use regime in BetmG articles 19a and 19b, whose single stated quantity is the 10 g of cannabis in article 19b(2), and it is not written for precursors at all. No separate traveller certificate for an ephedrine containing medicine was established in this dossier.
Documentation: Carry an ephedrine containing medicine in its original packaging showing the strength per dosage unit or per millilitre, because the exemption from the precursor entry is stated in exactly those terms and the figure on the box is what decides it. The provenance is Annex 7, list f of BetmVV-EDI in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, where the entry reads „Ephedrinhaltige Präparate“ with the stated low dose exemptions.

Switzerland, Ephedrine: BetmVV-EDI Annex 7, list f, entry „Ephedrinhaltige Präparate“ with exemptions at 15 mg per dosage unit or 10 mg per millilitre, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · precursor provisions apply instead of the article 19 drug ceiling. · Updated September 20, 2026

Ephedrine in Switzerland, full detail →

Etizolam

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries etizolam in list b, where the entry reads „Etizolam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Etizolam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Etizolam sits in list b of BetmVV-EDI, entered as „Etizolam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as etizolam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to etizolam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no etizolam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Etizolam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Etizolam: BetmVV-EDI Annex · list b · art. 1(2), entry „Etizolam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Etizolam in Switzerland, full detail →

Fentanyl

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries fentanyl in list a, where the entry reads „Fentanyl“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Fentanyl“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Fentanyl sits in list a of BetmVV-EDI, entered as „Fentanyl“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as fentanyl, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to fentanyl was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no fentanyl into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Fentanyl“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Fentanyl: BetmVV-EDI Annex · list a · art. 1(2), entry „Fentanyl“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Fentanyl in Switzerland, full detail →

Gabapentin

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for gabapentin. The German search term checked was „Gabapentin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry gabapentin, and separate product, medicines, food, tobacco or poisons law may still apply. It remains a prescription medicine under medicines law, which this row does not address.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for gabapentin under the search term „Gabapentin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It remains a prescription medicine under medicines law, which this row does not address.
If prescribed / medical: Gabapentin is not carried in lists a to e of BetmVV-EDI, the search under „Gabapentin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as gabapentin. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry gabapentin only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Gabapentin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Gabapentin: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Gabapentin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Gabapentin in Switzerland, full detail →

GBL

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries GBL in list a, where the entry reads „Gamma-Butyrolacton (GBL)“. The lactone is listed separately from the hydroxybutyrate, so the precursor relationship between them is not what does the work. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Gamma-Butyrolacton (GBL)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: GBL sits in list a of BetmVV-EDI, entered as „Gamma-Butyrolacton (GBL)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as GBL, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to GBL was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no GBL into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Gamma-Butyrolacton (GBL)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, GBL: BetmVV-EDI Annex · list a · art. 1(2), entry „Gamma-Butyrolacton (GBL)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

GBL in Switzerland, full detail →

GHB

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries GHB in list a, where the entry reads „Gamma-Hydroxybuttersäure (GHB)“. The acid is named directly, which is why a possession case does not have to argue from its lactone. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Gamma-Hydroxybuttersäure (GHB)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: GHB sits in list a of BetmVV-EDI, entered as „Gamma-Hydroxybuttersäure (GHB)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as GHB, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to GHB was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no GHB into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Gamma-Hydroxybuttersäure (GHB)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, GHB: BetmVV-EDI Annex · list a · art. 1(2), entry „Gamma-Hydroxybuttersäure (GHB)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

GHB in Switzerland, full detail →

Heroin

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries heroin in list d, where the entry reads „Heroin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Heroin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Heroin sits in list d of BetmVV-EDI, entered as „Heroin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as heroin, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to heroin was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no heroin into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Heroin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Heroin: BetmVV-EDI Annex · list d · art. 1(2), entry „Heroin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Heroin in Switzerland, full detail →

HHC

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries HHC in list e, where the entry reads „Hexahydrocannabinol (HHC)“. The hydrogenated cannabinoid is named in its own right rather than being left to the THC isomer clause. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „Hexahydrocannabinol (HHC)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: HHC sits in list e of BetmVV-EDI, entered as „Hexahydrocannabinol (HHC)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as HHC, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to HHC was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no HHC into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „Hexahydrocannabinol (HHC)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, HHC: BetmVV-EDI Annex · list e · art. 1(2), entry „Hexahydrocannabinol (HHC)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

HHC in Switzerland, full detail →

Hydrocodone

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries hydrocodone in list a, where the entry reads „Hydrocodon“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Hydrocodon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Hydrocodone sits in list a of BetmVV-EDI, entered as „Hydrocodon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as hydrocodone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to hydrocodone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no hydrocodone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Hydrocodon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Hydrocodone: BetmVV-EDI Annex · list a · art. 1(2), entry „Hydrocodon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Hydrocodone in Switzerland, full detail →

Ketamine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries ketamine in list b, where the entry reads „Ketamin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Ketamin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Ketamine sits in list b of BetmVV-EDI, entered as „Ketamin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as ketamine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to ketamine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no ketamine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Ketamin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Ketamine: BetmVV-EDI Annex · list b · art. 1(2), entry „Ketamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Ketamine in Switzerland, full detail →

Khat

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries khat in list d, where the entry reads „Catha edulis (Blätter und Zweigspitzen)“. The entry is written against the plant material itself, the leaves and the shoot tips, rather than against the cathinone it yields. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Catha edulis (Blätter und Zweigspitzen)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The entry is written against the plant material itself, the leaves and the shoot tips, rather than against the cathinone it yields. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Khat sits in list d of BetmVV-EDI, entered as „Catha edulis (Blätter und Zweigspitzen)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as khat, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to khat was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no khat into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Catha edulis (Blätter und Zweigspitzen)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Khat: BetmVV-EDI Annex · list d · art. 1(2), entry „Catha edulis (Blätter und Zweigspitzen)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Khat in Switzerland, full detail →

Kratom

Legal status: Controlled through its alkaloids. The plant name is not the operative entry, and BetmVV-EDI instead carries the principal alkaloids in list a, entered as „Mitragynin; 7-Hydroxymitragynin“, so a kratom product is classified by its actual contents and by the preparation rule. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Mitragynin; 7-Hydroxymitragynin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The plant name is not the operative entry, and the ordinance instead carries the principal alkaloids, so a kratom product is classified by its actual contents and by the preparation rule. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Kratom sits in list a of BetmVV-EDI, entered as „Mitragynin; 7-Hydroxymitragynin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as kratom, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to kratom was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no kratom into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Mitragynin; 7-Hydroxymitragynin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Kratom: BetmVV-EDI Annex · list a · art. 1(2), entry „Mitragynin · 7-Hydroxymitragynin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Kratom in Switzerland, full detail →

Lorazepam

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries lorazepam in list b, where the entry reads „Lorazepam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Lorazepam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Lorazepam sits in list b of BetmVV-EDI, entered as „Lorazepam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as lorazepam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to lorazepam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no lorazepam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Lorazepam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Lorazepam: BetmVV-EDI Annex · list b · art. 1(2), entry „Lorazepam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Lorazepam in Switzerland, full detail →

LSA (Morning Glory)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries LSA in list e, where the entry reads „Lysergsäureamid / Ergin“. The entry names the lysergamide by its chemical name and its common name together. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „Lysergsäureamid / Ergin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: LSA sits in list e of BetmVV-EDI, entered as „Lysergsäureamid / Ergin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as LSA, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to LSA was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no LSA into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „Lysergsäureamid / Ergin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, LSA: BetmVV-EDI Annex · list e · art. 1(2), entry „Lysergsäureamid / Ergin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

LSA (Morning Glory) in Switzerland, full detail →

LSD

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries LSD in list d, where the entry reads „LSD“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „LSD“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: LSD sits in list d of BetmVV-EDI, entered as „LSD“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as LSD, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to LSD was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no LSD into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „LSD“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, LSD: BetmVV-EDI Annex · list d · art. 1(2), entry „LSD“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

LSD in Switzerland, full detail →

MDA

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries MDA in list d, where the entry reads „MDA“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „MDA“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: MDA sits in list d of BetmVV-EDI, entered as „MDA“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as MDA, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to MDA was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no MDA into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „MDA“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, MDA: BetmVV-EDI Annex · list d · art. 1(2), entry „MDA“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

MDA in Switzerland, full detail →

MDMA

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries MDMA in list d, where the entry reads „MDMA“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „MDMA“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: MDMA sits in list d of BetmVV-EDI, entered as „MDMA“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as MDMA, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to MDMA was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no MDMA into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „MDMA“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, MDMA: BetmVV-EDI Annex · list d · art. 1(2), entry „MDMA“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

MDMA in Switzerland, full detail →

MDPV

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries MDPV in list d, where the entry reads „MDPV“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „MDPV“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: MDPV sits in list d of BetmVV-EDI, entered as „MDPV“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as MDPV, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to MDPV was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no MDPV into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „MDPV“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, MDPV: BetmVV-EDI Annex · list d · art. 1(2), entry „MDPV“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

MDPV in Switzerland, full detail →

Memantine

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for memantine. The German search term checked was „Memantin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry memantine, and separate product, medicines, food, tobacco or poisons law may still apply. It remains a prescription medicine under medicines law, which this row does not address.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for memantine under the search term „Memantin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It remains a prescription medicine under medicines law, which this row does not address.
If prescribed / medical: Memantine is not carried in lists a to e of BetmVV-EDI, the search under „Memantin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as memantine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry memantine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Memantin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Memantine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Memantin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Memantine in Switzerland, full detail →

Mephedrone (4-MMC)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries mephedrone in list d, where the entry reads „Mephedron (4-MMC)“. The entry carries the common abbreviation alongside the chemical name. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Mephedron (4-MMC)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Mephedrone sits in list d of BetmVV-EDI, entered as „Mephedron (4-MMC)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as mephedrone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to mephedrone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no mephedrone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Mephedron (4-MMC)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Mephedrone: BetmVV-EDI Annex · list d · art. 1(2), entry „Mephedron (4-MMC)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Mephedrone (4-MMC) in Switzerland, full detail →

Mescaline

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries mescaline in list d, where the entry reads „Meskalin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Meskalin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Mescaline sits in list d of BetmVV-EDI, entered as „Meskalin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as mescaline, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to mescaline was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no mescaline into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Meskalin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Mescaline: BetmVV-EDI Annex · list d · art. 1(2), entry „Meskalin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Mescaline in Switzerland, full detail →

Methadone

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries methadone in list a, where the entry reads „Methadon“. The entry stands whether the product is a substitution treatment formulation or not. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Methadon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Methadone sits in list a of BetmVV-EDI, entered as „Methadon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as methadone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to methadone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no methadone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Methadon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Methadone: BetmVV-EDI Annex · list a · art. 1(2), entry „Methadon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Methadone in Switzerland, full detail →

Methamphetamine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries methamphetamine in list a, where the entry reads „Methamphetamin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Methamphetamin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Methamphetamine sits in list a of BetmVV-EDI, entered as „Methamphetamin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as methamphetamine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to methamphetamine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no methamphetamine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Methamphetamin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Methamphetamine: BetmVV-EDI Annex · list a · art. 1(2), entry „Methamphetamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Methamphetamine in Switzerland, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries methaqualone in list a, where the entry reads „Methaqualon“. The quinazolinone sits with the narcotics rather than with the psychotropic list b sedatives. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Methaqualon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Methaqualone sits in list a of BetmVV-EDI, entered as „Methaqualon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as methaqualone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to methaqualone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no methaqualone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Methaqualon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Methaqualone: BetmVV-EDI Annex · list a · art. 1(2), entry „Methaqualon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Methaqualone (Quaaludes) in Switzerland, full detail →

Methylone

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries methylone in list d, where the entry reads „Methylon“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Methylon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Methylone sits in list d of BetmVV-EDI, entered as „Methylon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as methylone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to methylone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no methylone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Methylon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Methylone: BetmVV-EDI Annex · list d · art. 1(2), entry „Methylon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Methylone in Switzerland, full detail →

Methylphenidate

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries methylphenidate in list a, where the entry reads „Methylphenidat“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Methylphenidat“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Methylphenidate sits in list a of BetmVV-EDI, entered as „Methylphenidat“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as methylphenidate, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to methylphenidate was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no methylphenidate into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Methylphenidat“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Methylphenidate: BetmVV-EDI Annex · list a · art. 1(2), entry „Methylphenidat“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Methylphenidate in Switzerland, full detail →

Mitragynine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries mitragynine in list a, where the entry reads „Mitragynin“. The parent alkaloid is listed separately from its 7-hydroxy metabolite, and both together are what answer the kratom row. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Mitragynin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Mitragynine sits in list a of BetmVV-EDI, entered as „Mitragynin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as mitragynine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to mitragynine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no mitragynine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Mitragynin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Mitragynine: BetmVV-EDI Annex · list a · art. 1(2), entry „Mitragynin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Mitragynine in Switzerland, full detail →

Modafinil

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for modafinil. The German search term checked was „Modafinil“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry modafinil, and separate product, medicines, food, tobacco or poisons law may still apply. It remains a prescription medicine under medicines law, which this row does not address.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for modafinil under the search term „Modafinil“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It remains a prescription medicine under medicines law, which this row does not address.
If prescribed / medical: Modafinil is not carried in lists a to e of BetmVV-EDI, the search under „Modafinil“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as modafinil. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry modafinil only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Modafinil“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Modafinil: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Modafinil“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Modafinil in Switzerland, full detail →

Morphine

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries morphine in list a, where the entry reads „Morphin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Morphin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Morphine sits in list a of BetmVV-EDI, entered as „Morphin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as morphine, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to morphine was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no morphine into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Morphin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Morphine: BetmVV-EDI Annex · list a · art. 1(2), entry „Morphin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Morphine in Switzerland, full detail →

MXE

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries MXE in list d, where the entry reads „Methoxetamin (MXE)“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Methoxetamin (MXE)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: MXE sits in list d of BetmVV-EDI, entered as „Methoxetamin (MXE)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as MXE, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to MXE was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no MXE into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Methoxetamin (MXE)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, MXE: BetmVV-EDI Annex · list d · art. 1(2), entry „Methoxetamin (MXE)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

MXE in Switzerland, full detail →

Nicotine

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for nicotine. The German search term checked was „Nicotin / Nikotin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry nicotine, and separate product, medicines, food, tobacco or poisons law may still apply. Nicotine products are governed by product and tobacco law rather than by the drug schedules.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for nicotine under the search term „Nicotin / Nikotin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. Nicotine products are governed by product and tobacco law rather than by the drug schedules.
If prescribed / medical: Nicotine is not carried in lists a to e of BetmVV-EDI, the search under „Nicotin / Nikotin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as nicotine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry nicotine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Nicotin / Nikotin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Nicotine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Nicotin / Nikotin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Nicotine in Switzerland, full detail →

Nimetazepam

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries nimetazepam in list b, where the entry reads „Nimetazepam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Nimetazepam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Nimetazepam sits in list b of BetmVV-EDI, entered as „Nimetazepam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as nimetazepam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to nimetazepam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no nimetazepam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Nimetazepam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Nimetazepam: BetmVV-EDI Annex · list b · art. 1(2), entry „Nimetazepam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Nimetazepam in Switzerland, full detail →

Nitrous Oxide

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for nitrous oxide. The German search term checked was „Distickstoffoxid / Lachgas“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry nitrous oxide, and separate product, medicines, food, tobacco or poisons law may still apply. Supply and sale of the gas can still be reached by product safety and chemicals law.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for nitrous oxide under the search term „Distickstoffoxid / Lachgas“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. Supply and sale of the gas can still be reached by product safety and chemicals law.
If prescribed / medical: Nitrous oxide is not carried in lists a to e of BetmVV-EDI, the search under „Distickstoffoxid / Lachgas“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as nitrous oxide. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry nitrous oxide only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Distickstoffoxid / Lachgas“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Nitrous oxide: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Distickstoffoxid / Lachgas“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Nitrous Oxide in Switzerland, full detail →

Opium

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries opium in list a, where the entry reads „Opium“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Opium“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Opium sits in list a of BetmVV-EDI, entered as „Opium“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as opium, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to opium was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no opium into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Opium“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Opium: BetmVV-EDI Annex · list a · art. 1(2), entry „Opium“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Opium in Switzerland, full detail →

Oxycodone

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries oxycodone in list a, where the entry reads „Oxycodon“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Oxycodon“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Oxycodone sits in list a of BetmVV-EDI, entered as „Oxycodon“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as oxycodone, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to oxycodone was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no oxycodone into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Oxycodon“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Oxycodone: BetmVV-EDI Annex · list a · art. 1(2), entry „Oxycodon“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Oxycodone in Switzerland, full detail →

PCP

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries PCP in list a, where the entry reads „Phencyclidin (PCP)“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list a entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list a placement of the entry „Phencyclidin (PCP)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: PCP sits in list a of BetmVV-EDI, entered as „Phencyclidin (PCP)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list a substance such as PCP, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to PCP was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no PCP into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list a entry reads „Phencyclidin (PCP)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, PCP: BetmVV-EDI Annex · list a · art. 1(2), entry „Phencyclidin (PCP)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

PCP in Switzerland, full detail →

Peyote

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries peyote in list d, where the entry reads „Lophophora williamsii (Peyote)“. The entry is written against the cactus by its botanical name, so the plant is reached without an argument through its mescaline content. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Lophophora williamsii (Peyote)“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. The entry is written against the cactus by its botanical name, so the plant is reached without an argument through its mescaline content. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Peyote sits in list d of BetmVV-EDI, entered as „Lophophora williamsii (Peyote)“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as peyote, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to peyote was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no peyote into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Lophophora williamsii (Peyote)“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Peyote: BetmVV-EDI Annex · list d · art. 1(2), entry „Lophophora williamsii (Peyote)“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Peyote in Switzerland, full detail →

Phenibut

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for phenibut. The German search term checked was „Phenibut“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry phenibut, and separate product, medicines, food, tobacco or poisons law may still apply. No medicines authorisation for it in Switzerland was established in this dossier either.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for phenibut under the search term „Phenibut“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. No medicines authorisation for it in Switzerland was established in this dossier either.
If prescribed / medical: Phenibut is not carried in lists a to e of BetmVV-EDI, the search under „Phenibut“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as phenibut. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry phenibut only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Phenibut“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Phenibut: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Phenibut“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Phenibut in Switzerland, full detail →

Pink Cocaine / Tusi

Legal status: Not applicable as a single status, and not because the ordinance is silent. Pink cocaine is a street label rather than a substance: the source records „kein festes Gemisch; Einordnung nach tatsächlichen Bestandteilen“, no fixed mixture, classification according to the actual constituents. Swiss control is closed and works entry by entry, so a powder sold under this name is whatever it analyses as, and the same name can produce different results from one sample to the next. The constituents reported under it are answered separately in this table, and those rows, not this one, carry the schedule placements. No single terminal status can honestly be stated for the label itself.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and beyond that no single ceiling can be stated for the label, because the label does not identify a substance. Where a sample contains a controlled constituent, that constituent engages BetmG article 19, whose aggravated forms come from article 19(2) and whose 20 year maximum comes from StGB article 40; where it contains none, no drug offence arises from the schedules at all. The 20 year maximum that StGB article 40 supplies for a BetmG article 19 offence therefore attaches to a constituent and never to the name on the packet. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: The country level rule in this dossier is the personal use regime of BetmG articles 19a and 19b, with article 19b(2) fixing 10 g of cannabis as the only stated negligible quantity. That rule cannot be attached to a schedule placement for pink cocaine, because the label has no placement of its own; it attaches instead to whichever constituent is actually present, and each of those has its own row here. There is no medical product and no prescription route under this name, so nothing in this cell should be read as a lawful carriage route.
Documentation: Carry nothing sold under this name expecting a result from this row, because the row records that the name does not fix a composition. The provenance is BetmVV-EDI in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, which carries no entry under the label and has to be applied constituent by constituent; the source dossier marked the row not applicable, and that treatment is kept here because a variable mixture cannot have one terminal Swiss answer.

Switzerland, Pink cocaine: BetmVV-EDI lists a to e applied constituent by constituent, source note „kein festes Gemisch · Einordnung nach tatsächlichen Bestandteilen“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · kept as not applicable because the label names a variable mixture rather than a substance. · Updated September 20, 2026

Pink Cocaine / Tusi in Switzerland, full detail →

Poppers

Legal status: Not applicable as a single status, because poppers is a use name and not a substance name. The source records „kein einheitlicher Stoffname; Einordnung nach tatsächlichem Alkylnitrit“, no single substance name, classification according to the alkyl nitrite actually present. Several different alkyl nitrites are sold under the one word and they cannot share a single Swiss result, since the ordinance works from named entries and each nitrite would have to be searched under its own German name. Only one of them, amyl nitrite, was searched in this build, and that row returned a negative closed list result; the others were not individually checked, so the label as a whole has no settled status here.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and beyond that no single ceiling can be stated for the label, because the label does not identify a substance. If a particular alkyl nitrite were found in lists a to e, the drug act's offence articles would apply to it, with the aggravated forms in article 19(2) and the 20 year maximum from StGB article 40; on the single nitrite searched here nothing was found, which points away from a drug schedule penalty but proves it for that nitrite alone. The 20 year maximum that StGB article 40 supplies for a BetmG article 19 offence therefore attaches to a constituent and never to the name on the packet. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: The country level rule this dossier establishes, the personal use regime in BetmG articles 19a and 19b with 10 g of cannabis as the only stated negligible quantity in article 19b(2), operates on controlled substances, and no controlled substance has been identified under this name. There is therefore no schedule placement to attach it to, and no prescription route exists for a product sold as poppers. The one member searched here, amyl nitrite, is not in lists a to e, and that is the limit of what this cell can state.
Documentation: Carry a poppers product only on the footing that the actual alkyl nitrite inside decides everything, and keep the container with its own labelling so that the substance can be identified rather than guessed at. The provenance is BetmVV-EDI in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, together with the negative search under „Amylnitrit“ recorded in the amyl nitrite row of this same table; the source dossier marked this row not applicable and that treatment is kept, because one result cannot cover several different nitrites.

Switzerland, Poppers: BetmVV-EDI lists a to e searched nitrite by nitrite, source note „kein einheitlicher Stoffname · Einordnung nach tatsächlichem Alkylnitrit“, with the negative search under „Amylnitrit“ in the companion row, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · kept as not applicable because the use name covers several alkyl nitrites. · Updated September 20, 2026

Poppers in Switzerland, full detail →

Pregabalin

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for pregabalin. The German search term checked was „Pregabalin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry pregabalin, and separate product, medicines, food, tobacco or poisons law may still apply. It remains a prescription medicine under medicines law, which this row does not address.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for pregabalin under the search term „Pregabalin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It remains a prescription medicine under medicines law, which this row does not address.
If prescribed / medical: Pregabalin is not carried in lists a to e of BetmVV-EDI, the search under „Pregabalin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as pregabalin. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry pregabalin only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Pregabalin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Pregabalin: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Pregabalin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Pregabalin in Switzerland, full detail →

Psilocybin

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries psilocybin in list d, where the entry reads „Psilocybin“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Psilocybin“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Psilocybin sits in list d of BetmVV-EDI, entered as „Psilocybin“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as psilocybin, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to psilocybin was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no psilocybin into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Psilocybin“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Psilocybin: BetmVV-EDI Annex · list d · art. 1(2), entry „Psilocybin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Psilocybin in Switzerland, full detail →

Quetiapine

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for quetiapine. The German search term checked was „Quetiapin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry quetiapine, and separate product, medicines, food, tobacco or poisons law may still apply. It remains a prescription medicine under medicines law, which this row does not address.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for quetiapine under the search term „Quetiapin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It remains a prescription medicine under medicines law, which this row does not address.
If prescribed / medical: Quetiapine is not carried in lists a to e of BetmVV-EDI, the search under „Quetiapin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as quetiapine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry quetiapine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Quetiapin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Quetiapine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Quetiapin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Quetiapine in Switzerland, full detail →

Salvia divinorum

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries Salvia divinorum in list d, where the entry reads „Salvia divinorum; Salvinorin A“. Both the plant and its active diterpene are named, so neither the leaf nor an extract depends on the other's entry. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list d entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list d placement of the entry „Salvia divinorum; Salvinorin A“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Salvia divinorum sits in list d of BetmVV-EDI, entered as „Salvia divinorum; Salvinorin A“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list d substance such as Salvia divinorum, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to Salvia divinorum was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no Salvia divinorum into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list d entry reads „Salvia divinorum; Salvinorin A“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Salvia divinorum: BetmVV-EDI Annex · list d · art. 1(2), entry „Salvia divinorum · Salvinorin A“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Salvia divinorum in Switzerland, full detail →

Scopolamine (Devil's Breath)

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for scopolamine. The German search term checked was „Scopolamin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry scopolamine, and separate product, medicines, food, tobacco or poisons law may still apply. The alkaloid is governed as a medicine and, in plant form, by whatever other law reaches the plant.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for scopolamine under the search term „Scopolamin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. The alkaloid is governed as a medicine and, in plant form, by whatever other law reaches the plant.
If prescribed / medical: Scopolamine is not carried in lists a to e of BetmVV-EDI, the search under „Scopolamin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as scopolamine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry scopolamine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Scopolamin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Scopolamine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Scopolamin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Scopolamine (Devil's Breath) in Switzerland, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Not applicable as a class status, because Switzerland controls these compounds one at a time and by defined family. The source row records „JWH-018; AB-CHMINACA; weitere einzeln benannte oder von Verzeichnis e erfasste Stoffe“, individually named compounds together with further substances caught by list e. List e is broad only where its own defined families apply, and BetmVV-EDI article 1 makes the control set closed, so a compound that is neither named nor inside a defined family is not controlled merely because it acts on the same receptors. A product sold as a synthetic cannabinoid can therefore fall inside or outside the ordinance depending on the exact compound, which is why no single terminal status is stated here.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and beyond that no single ceiling can be stated for the label, because the label does not identify a substance. A named compound such as JWH-018 or AB-CHMINACA, or one caught by a defined family in list e, engages BetmG article 19, with the aggravated forms in article 19(2) and the 20 year maximum supplied by StGB article 40. The 20 year maximum that StGB article 40 supplies for a BetmG article 19 offence therefore attaches to a constituent and never to the name on the packet. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: The personal use regime in BetmG articles 19a and 19b is the country level rule this dossier establishes, and article 19b(2) fixes its only stated quantity at 10 g of cannabis, a figure that belongs to the cannabis entries and not to these compounds. The class has no schedule placement of its own to attach that rule to, because placement follows the individual compound, either as a named entry or through a defined family in list e. No synthetic cannabinoid has an authorised medical form or a prescription route on the facts recorded in this dossier.
Documentation: Carry no product sold as a synthetic cannabinoid on the assumption that this row clears it, because the row records a class that resolves compound by compound. The provenance is BetmVV-EDI article 1 and list e in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the individually named examples „JWH-018; AB-CHMINACA“ recorded by the source; the not applicable treatment is kept here because a class defined by its effect cannot share one Swiss classification.

Switzerland, Synthetic cannabinoids: BetmVV-EDI article 1 with the defined families of list e and the individually named entries „JWH-018 · AB-CHMINACA“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026 · kept as not applicable because control runs compound by compound. · Updated September 20, 2026

Synthetic Cannabinoids (K2 / Spice) in Switzerland, full detail →

THC-P

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries THC-P in list e, where the entry reads „Δ9-THCP; Δ8-THCP“. The entry names both of the phorol homologues expressly, so neither variant depends on an argument from resemblance. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list e entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list e placement of the entry „Δ9-THCP; Δ8-THCP“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: THC-P sits in list e of BetmVV-EDI, entered as „Δ9-THCP; Δ8-THCP“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list e substance such as THC-P, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to THC-P was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no THC-P into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list e entry reads „Δ9-THCP; Δ8-THCP“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, THC-P: BetmVV-EDI Annex · list e · art. 1(2), entry „Δ9-THCP · Δ8-THCP“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

THC-P in Switzerland, full detail →

Tobacco

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for tobacco. The German search term checked was „Tabak“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry tobacco, and separate product, medicines, food, tobacco or poisons law may still apply. Tobacco is governed by its own product and taxation law, which this row does not touch.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for tobacco under the search term „Tabak“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. Tobacco is governed by its own product and taxation law, which this row does not touch.
If prescribed / medical: Tobacco is not carried in lists a to e of BetmVV-EDI, the search under „Tabak“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as tobacco. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry tobacco only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Tabak“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Tobacco: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Tabak“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Tobacco in Switzerland, full detail →

Tramadol

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries tramadol in list b, where the entry reads „Tramadol“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Tramadol“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Tramadol sits in list b of BetmVV-EDI, entered as „Tramadol“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as tramadol, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to tramadol was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no tramadol into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Tramadol“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Tramadol: BetmVV-EDI Annex · list b · art. 1(2), entry „Tramadol“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Tramadol in Switzerland, full detail →

Xanax (Alprazolam)

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries alprazolam in list b, where the entry reads „Alprazolam“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Alprazolam“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Alprazolam sits in list b of BetmVV-EDI, entered as „Alprazolam“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as alprazolam, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to alprazolam was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no alprazolam into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Alprazolam“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Alprazolam: BetmVV-EDI Annex · list b · art. 1(2), entry „Alprazolam“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Xanax (Alprazolam) in Switzerland, full detail →

Xylazine

Legal status: Not scheduled. The federal schedule ordinance BetmVV-EDI records no entry for xylazine. The German search term checked was „Xylazin“, and nothing was found in lists a to e, nor does any article 1(2) extension for salts, esters, ethers, carbamates, stereoisomers or preparations reach it from a listed substance. Swiss control is closed, so absence from the lists is a substantive answer and not an oversight, but it is a narrow one: this row proves only that the drug schedules do not carry xylazine, and separate product, medicines, food, tobacco or poisons law may still apply. It is a veterinary medicine, and veterinary medicines law governs it instead.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty, and on this row there is no BetmG article 19 ceiling at all, because the negative closed list result proved for xylazine under the search term „Xylazin“ means the drug act's offence articles are not engaged by the substance itself. Neither the aggravated forms in article 19(2) nor the 20 year maximum that StGB article 40 supplies for drug offences attaches here, and nothing in lists a to e nor any article 1(2) extension reaches it from a listed substance. It is a veterinary medicine, and veterinary medicines law governs it instead.
If prescribed / medical: Xylazine is not carried in lists a to e of BetmVV-EDI, the search under „Xylazin“ having returned nothing, so there is no controlled substance authorisation to obtain for it, and the one country level rule this dossier establishes does not bite. That rule is the personal use regime: BetmG article 19a punishes unauthorised consumption of a controlled substance, article 19b makes a negligible quantity prepared for one's own consumption nonpunishable, and article 19b(2) fixes that quantity at 10 g of cannabis alone. None of those articles reaches an unscheduled substance such as xylazine. No Swiss prescription route or traveller certificate for it was established in this dossier, and any medicines law requirement attaching to the product form was outside what this build verified.
Documentation: Carry xylazine only in the form and quantity the rest of Swiss law allows, because this row settles the drug schedules and nothing else, and keep any prescribed product in its original packaging with the prescription so that the product form can be identified at a control. The provenance is the negative search of the EDI ordinance BetmVV-EDI under „Xylazin“, run across lists a to e and the article 1 extensions in the German consolidation dated 13 March 2026, read at Fedlex on 18 September 2026, with the 94 page compilation read through its final page so that no further drug schedule was left unchecked.

Switzerland, Xylazine: BetmVV-EDI article 1 with Annexes 1 to 6 covering lists a to e, negative search under „Xylazin“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Xylazine in Switzerland, full detail →

Zolpidem

Legal status: Controlled. The federal schedule ordinance BetmVV-EDI carries zolpidem in list b, where the entry reads „Zolpidem“. Article 1 of the ordinance defines the controlled set as narcotics, psychotropic substances, raw materials and products with a presumed narcotic like effect, precursors and auxiliary chemicals, and article 1(2) then extends each named entry to its salts, esters, ethers, carbamates and stereoisomers and to preparations containing it. The model is closed but extended, so a chemical resemblance to the list b entry is not by itself enough to bring a compound inside it. Article 2 assigns lists a to d to Annexes 1 to 5 and list e to Annex 6. The German consolidation read for this row is dated 13 March 2026, and the German, French and Italian texts are equally authoritative.
Consequences if caught: Capital exposure: none. Switzerland has no death penalty and the Betäubungsmittelgesetz authorises no life term either, so the ceiling is 20 years: BetmG article 19(2) defines the aggravated forms of the offence and StGB article 40 supplies that maximum precisely because the drug act does not reach beyond it. What brings street conduct inside article 19 at all is the list b placement of the entry „Zolpidem“ rather than the weight carried; quantity then separates the ordinary case from the aggravated serious case. Switzerland fits none of the three threshold models cleanly, because it combines one federal statutory cannabis figure, substance specific Federal Supreme Court thresholds for the aggravated serious case, and conduct based offences for which quantity is not the sole determinant, so no settled weight can be quoted here. Unauthorised consumption is a separate offence under BetmG article 19a and is not silently treated as trafficking.
If prescribed / medical: Zolpidem sits in list b of BetmVV-EDI, entered as „Zolpidem“, and the only country level rule this dossier establishes for a person carrying a drug in Switzerland is the personal use regime: BetmG article 19a keeps unauthorised intentional consumption punishable in its own right, article 19b makes the preparation of a negligible quantity for one's own consumption nonpunishable, together with qualifying free sharing for simultaneous joint consumption, and article 19b(2) fixes that negligible quantity at 10 g of cannabis and at nothing else. The figure is federal law rather than a cantonal tolerance, so it gives no margin to a list b substance such as zolpidem, and cantonal police and prosecutors administer the rule without being able to replace it. No prescription, import certificate or traveller exemption specific to zolpidem was established in this dossier, so nothing here authorises a foreign prescription at the Swiss border.
Documentation: Carry no zolpidem into Switzerland on the strength of this row, and keep any medicine you are lawfully entitled to in its original dispensing packaging with the prescription and a prescriber's letter naming the patient, the active ingredient and the dose. The provenance is the EDI ordinance BetmVV-EDI in its German consolidation dated 13 March 2026, read at the Fedlex classified compilation on 18 September 2026, where the list b entry reads „Zolpidem“; the penalty articles are BetmG article 19 with StGB article 40 supplying the 20 year maximum, and the 94 page consolidation was read through its final page, so no further drug schedule follows it.

Switzerland, Zolpidem: BetmVV-EDI Annex · list b · art. 1(2), entry „Zolpidem“, at https://www.fedlex.admin.ch/eli/cc/2011/363/de · BetmG articles 19, 19a and 19b at https://www.fedlex.admin.ch/eli/cc/1952/241_241_245/de · Swiss Criminal Code article 40 at https://www.fedlex.admin.ch/eli/cc/54/757_781_799/de · German consolidation dated 13 March 2026, read 18 September 2026. · Updated September 20, 2026

Zolpidem in Switzerland, full detail →

Not individually verified

1 substance is not individually verified for Switzerland

For these the governing national drug law is cited, but we have not verified that the substance specifically is scheduled under it. Treat them as unanswered, not as legal. Confirm with Switzerland’s drug authority or your embassy.

Substance	What we found
Amanita muscaria	Not confirmed. BetmVV-EDI carries muscimol as an individual entry in list a at Annex 2, but this build found no...

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index